Simian immunodeficiency virus infection in the brain and lung leads to differential type I IFN signaling during acute infection

Journal of Immunology

Volumn 186, Issue 7, 2011, Pages 4008-4018

  Alammar, Luna ^a   Gama, Lucio ^a   Clements, Janice E ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ALPHA INTERFERON RECEPTOR; BETA INTERFERON; BETA INTERFERON RECEPTOR; FOCAL ADHESION KINASE 1; INTERFERON; INTERFERON REGULATORY FACTOR 7; STAT1 PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INFECTION; CONTROLLED STUDY; DOWN REGULATION; DOWNSTREAM PROCESSING; ENZYME ACTIVATION; LUNG INFECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SIMIAN IMMUNODEFICIENCY VIRUS; TRANSCRIPTION REGULATION; TRANSLATION REGULATION; UPREGULATION;

ACUTE DISEASE; ANIMALS; DISEASE MODELS, ANIMAL; DOWN-REGULATION; ENCEPHALITIS, VIRAL; INTERFERON-ALPHA; LUNG DISEASES; MACACA NEMESTRINA; PARIETAL LOBE; RNA, MESSENGER; SIGNAL TRANSDUCTION; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 79955007532     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1003757     Document Type: Article

References (76)

1. Maschke, M., O. Kastrup, S. Esser, B. Ross, U. Hengge, and A. Hufnagel. 2000. Incidence and prevalence of neurological disorders associated with HIV since the introduction of highly active antiretroviral therapy (HAART). J. Neurol. Neurosurg. Psychiatry 69: 376-380. (Pubitemid 30636242)
2. McArthur, J. C., N. Haughey, S. Gartner, K. Conant, C. Pardo, A. Nath, and N. Sacktor. 2003. Human immunodeficiency virus-associated dementia: An evolving disease. J. Neurovirol. 9: 205-221. (Pubitemid 36656454)
3. Sacktor, N., M. P. McDermott, K. Marder, G. Schifitto, O. A. Selnes, J. C. McArthur, Y. Stern, S. Albert, D. Palumbo, K. Kieburtz, et al. 2002. HIVassociated cognitive impairment before and after the advent of combination therapy. J. Neurovirol. 8: 136-142. (Pubitemid 34520894)
4. Fischer-Smith, T., and J. Rappaport. 2005. Evolving paradigms in the pathogenesis of HIV-1-associated dementia. Expert Rev. Mol. Med. 7: 1-26.
5. Marra, C. M., Y. Zhao, D. B. Clifford, S. Letendre, S. Evans, K. Henry, R. J. Ellis, B. Rodriguez, R. W. Coombs, G. Schifitto, et al; AIDS Clinical Trials Group 736 Study Team. 2009. Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance. AIDS 23: 1359-1366.
6. Ellis, R. J., D. Rosario, D. B. Clifford, J. C. McArthur, D. Simpson, T. Alexander, B. B. Gelman, F. Vaida, A. Collier, C. M. Marra, et al; CHARTER Study Group. 2010. Continued high prevalence and adverse clinical impact of human immunodeficiency virus-associated sensory neuropathy in the era of combination antiretroviral therapy: The CHARTER Study. Arch. Neurol. 67: 552-558.
7. Letendre, S. L., R. J. Ellis, B. M. Ances, and J. A. McCutchan. 2010. Neurologic complications of HIV disease and their treatment. Top. HIV Med. 18: 45-55.
8. Mankowski, J. L., J. E. Clements, and M. C. Zink. 2002. Searching for clues: Tracking the pathogenesis of human immunodeficiency virus central nervous system disease by use of an accelerated, consistent simian immunodeficiency virus macaque model. J. Infect. Dis. 186(Suppl 2): S199-S208. (Pubitemid 35370482)
9. Witwer, K. W., L. Gama, M. Li, C. M. Bartizal, S. E. Queen, J. J. Varrone, A. K. Brice, D. R. Graham, P. M. Tarwater, J. L. Mankowski, et al. 2009. Coordinated regulation of SIV replication and immune responses in the CNS. PLoS ONE 4: E8129.
10. Zink, M. C., K. Suryanarayana, J. L. Mankowski, A. Shen, M. Piatak, Jr., J. P. Spelman, D. L. Carter, R. J. Adams, J. D. Lifson, and J. E. Clements. 1999.High viral load in the cerebrospinal fluid and brain correlates with severity of simian immunodeficiency virus encephalitis. J. Virol. 73: 10480-10488.
11. Clements, J. E., T. Babas, J. L. Mankowski, K. Suryanarayana, M. Piatak, Jr., P. M. Tarwater, J. D. Lifson, and M. C. Zink. 2002. The central nervous system as a reservoir for simian immunodeficiency virus (SIV): Steady-state levels of SIV DNA in brain from acute through asymptomatic infection. J. Infect. Dis. 186: 905-913.
12. Szubin, R., W. L. Chang, T. Greasby, L. Beckett, and N. Baumgarth. 2008. Rigid interferon-alpha subtype responses of human plasmacytoid dendritic cells. J. Interferon Cytokine Res. 28: 749-763. (Pubitemid 352773932)
13. Lin, R., C. Heylbroeck, P. M. Pitha, and J. Hiscott. 1998. Virus-dependent phosphorylation of the IRF-3 transcription factor regulates nuclear translocation, transactivation potential, and proteasome-mediated degradation. Mol. Cell. Biol. 18: 2986-2996. (Pubitemid 28183468)
14. Sato, M., N. Tanaka, N. Hata, E. Oda, and T. Taniguchi. 1998. Involvement of the IRF family transcription factor IRF-3 in virus-induced activation of the IFNbeta gene. FEBS Lett. 425: 112-116. (Pubitemid 28149751)
15. Kawai, T., and S. Akira. 2007. Antiviral signaling through pattern recognition receptors. J. Biochem. 141: 137-145. (Pubitemid 46775751)
16. Yoneyama, M., W. Suhara, Y. Fukuhara, M. Fukuda, E. Nishida, and T. Fujita. 1998. Direct triggering of the type I interferon system by virus infection: Activation of a transcription factor complex containing IRF-3 and CBP/p300. EMBO J. 17: 1087-1095. (Pubitemid 28077662)
17. Barber, S. A., D. S. Herbst, B. T. Bullock, L. Gama, and J. E. Clements. 2004. Innate immune responses and control of acute simian immunodeficiency virus replication in the central nervous system. J. Neurovirol. 10(Suppl 1): 15-20. (Pubitemid 38325088)
18. Barber, S. A., L. Gama, J. M. Dudaronek, T. Voelker, P. M. Tarwater, and J. E. Clements. 2006. Mechanism for the establishment of transcriptional HIV latency in the brain in a simian immunodeficiency virus-macaque model. J. Infect. Dis. 193: 963-970.
19. Dudaronek, J. M., S. A. Barber, and J. E. Clements. 2007. CUGBP1 is required for IFNbeta-mediated induction of dominant-negative CEBPbeta and suppression of SIV replication in macrophages. J. Immunol. 179: 7262-7269.
20. Meltzer, M. S., L. Baca, J. A. Turpin, D. C. Kalter, C. Dieffenbach, R. M. Friedman, and H. E. Gendelman. 1991. Regulation of cytokine and viral gene expression in monocytes infected with the human immunodeficiency virus. Pathobiology 59: 209-213.
21. Griffin, D. E. 2003. Immune responses to RNA-virus infections of the CNS. Nat. Rev. Immunol. 3: 493-502. (Pubitemid 37339189)
22. Akwa, Y., D. E. Hassett, M. L. Eloranta, K. Sandberg, E. Masliah, H. Powell, J. L. Whitton, F. E. Bloom, and I. L. Campbell. 1998. Transgenic expression of IFN-alpha in the central nervous system of mice protects against lethal neurotropic viral infection but induces inflammation and neurodegeneration. J. Immunol. 161: 5016-5026. (Pubitemid 28492084)
23. Teige, I., A. Treschow, A. Teige, R. Mattsson, V. Navikas, T. Leanderson, R. Holmdahl, and S. Issazadeh-Navikas. 2003. IFN-beta gene deletion leads to augmented and chronic demyelinating experimental autoimmune encephalomyelitis. J. Immunol. 170: 4776-4784. (Pubitemid 36519987)
24. Mankowski, J. L., D. L. Carter, J. P. Spelman, M. L. Nealen, K. R. Maughan, L. M. Kirstein, P. J. Didier, R. J. Adams, M. Murphey-Corb, and M. C. Zink. 1998. Pathogenesis of simian immunodeficiency virus pneumonia: An immunopathological response to virus. Am. J. Pathol. 153: 1123-1130. (Pubitemid 28465835)
25. Baskin, G. B., M. Murphey-Corb, L. N. Martin, K. F. Soike, F. S. Hu, and D. Kuebler. 1991. Lentivirus-induced pulmonary lesions in rhesus monkeys (Macaca mulatta) infected with simian immunodeficiency virus. Vet. Pathol. 28: 506-513.
26. van't Wout, A. B., L. J. Ran, C. L. Kuiken, N. A. Kootstra, S. T. Pals, and H. Schuitemaker. 1998. Analysis of the temporal relationship between human immunodeficiency virus type 1 quasispecies in sequential blood samples and various organs obtained at autopsy. J. Virol. 72: 488-496. (Pubitemid 28048863)
27. Livak, K. J., and T. D. Schmittgen. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408. (Pubitemid 34164012)
28. Barratt-Boyes, S. M., V. Wijewardana, and K. N. Brown. 2010. In acute pathogenic SIV infection plasmacytoid dendritic cells are depleted from blood and lymph nodes despite mobilization. J. Med. Primatol. 39: 235-242.
29. Brown, K. N., V. Wijewardana, X. Liu, and S. M. Barratt-Boyes. 2009. Rapid influx and death of plasmacytoid dendritic cells in lymph nodes mediate depletion in acute simian immunodeficiency virus infection. PLoS Pathog. 5: E1000413.
30. Barber, S. A., L. Gama, M. Li, T. Voelker, J. E. Anderson, M. C. Zink, P. M. Tarwater, L. M. Carruth, and J. E. Clements. 2006. Longitudinal analysis of simian immunodeficiency virus (SIV) replication in the lungs: Compartmentalized regulation of SIV. J. Infect. Dis. 194: 931-938. (Pubitemid 44454079)
31. Ma, X., J. M. Chow, G. Gri, G. Carra, F. Gerosa, S. F. Wolf, R. Dzialo, and G. Trinchieri. 1996. The interleukin 12 p40 gene promoter is primed by interferon gamma in monocytic cells. J. Exp. Med. 183: 147-157. (Pubitemid 26028754)
32. Yoshida, A., Y. Koide, M. Uchijima, and T. O. Yoshida. 1994. IFN-gamma induces IL-12 mRNA expression by a murine macrophage cell line, J774. Biochem. Biophys. Res. Commun. 198: 857-861.
33. Rani, M. R., S. Pandalai, J. Shrock, A. Almasan, and R. M. Ransohoff. 2007. Requirement of catalytically active Tyk2 and accessory signals for the induction of TRAIL mRNA by IFN-beta. J. Interferon Cytokine Res. 27: 767-779. (Pubitemid 47479861)
34. Lu, R., P. A. Moore, and P. M. Pitha. 2002. Stimulation of IRF-7 gene expression by tumor necrosis factor alpha: Requirement for NFkappa B transcription factor and gene accessibility. J. Biol. Chem. 277: 16592-16598. (Pubitemid 34967676)
35. Ousman, S. S., J. Wang, and I. L. Campbell. 2005. Differential regulation of interferon regulatory factor (IRF)-7 and IRF-9 gene expression in the central nervous system during viral infection. J. Virol. 79: 7514-7527. (Pubitemid 40756787)
36. Abel, K., M. J. Alegria-Hartman, K. Rothaeusler, M. Marthas, and C. J. Miller. 2002. The relationship between simian immunodeficiency virus RNA levels and the mRNA levels of alpha/beta interferons (IFN-alpha/beta) and IFN-alpha/betainducible Mx in lymphoid tissues of rhesus macaques during acute and chronic infection. J. Virol. 76: 8433-8445. (Pubitemid 34809095)
37. Radvanyi, L. G., A. Banerjee, M. Weir, and H. Messner. 1999. Low levels of interferon-alpha induce CD86 (B7.2) expression and accelerates dendritic cell maturation from human peripheral blood mononuclear cells. Scand. J. Immunol. 50: 499-509. (Pubitemid 29503456)
38. Honda, K., A. Takaoka, and T. Taniguchi. 2006. Type I interferon [corrected] gene induction by the interferon regulatory factor family of transcription factors. Immunity 25: 349-360. (Pubitemid 44354220)
39. Colamonici, O. R., H. Uyttendaele, P. Domanski, H. Yan, and J. J. Krolewski. 1994. p135Tyk2, an interferon-alpha-activated tyrosine kinase, is physically associated with an interferon-alpha receptor. J. Biol. Chem. 269: 3518-3522.
40. Velazquez, L., M. Fellous, G. R. Stark, and S. Pellegrini. 1992. A protein tyrosine kinase in the interferon alpha/beta signaling pathway. Cell 70: 313-322.
41. Velazquez, L., K. E. Mogensen, G. Barbieri, M. Fellous, G. Uzé, and S. Pellegrini. 1995. Distinct domains of the protein tyrosine kinase Tyk2 required for binding of interferon-alpha/beta and for signal transduction. J. Biol. Chem. 270: 3327-3334.
42. Uzé, G., G. Schreiber, J. Piehler, and S. Pellegrini. 2007. The receptor of the type I interferon family. Curr. Top. Microbiol. Immunol. 316: 71-95.
43. Gauzzi, M. C., G. Barbieri, M. F. Richter, G. Uzé, L. Ling, M. Fellous, and S. Pellegrini. 1997. The amino-terminal region of Tyk2 sustains the level of interferon alpha receptor 1, a component of the interferon alpha/beta receptor. Proc. Natl. Acad. Sci. USA 94: 11839-11844. (Pubitemid 27467804)
44. Platis, D., and G. R. Foster. 2003. Activity of hybrid type I interferons in cells lacking Tyk2: A common region of IFN-alpha 8 induces a response, but IFNalpha2/ 8 hybrids can behave like IFN-beta. J. Interferon Cytokine Res. 23: 655-666. (Pubitemid 37452906)
45. Jaitin, D. A., L. C. Roisman, E. Jaks, M. Gavutis, J. Piehler, J. Van der Heyden, G. Uze, and G. Schreiber. 2006. Inquiring into the differential action of interferons (IFNs): An IFN-alpha2 mutant with enhanced affinity to IFNAR1 is functionally similar to IFN-beta. Mol. Cell. Biol. 26: 1888-1897.
46. Xu, H., H. An, J. Hou, C. Han, P. Wang, Y. Yu, and X. Cao. 2008. Phosphatase PTP1B negatively regulates MyD88- and TRIF-dependent proinflammatory cytokine and type I interferon production in TLR-triggered macrophages. Mol. Immunol. 45: 3545-3552.
47. Myers, M. P., J. N. Andersen, A. Cheng, M. L. Tremblay, C. M. Horvath, J. P. Parisien, A. Salmeen, D. Barford, and N. K. Tonks. 2001. TYK2 and JAK2 are substrates of protein-tyrosine phosphatase 1B. J. Biol. Chem. 276: 47771-47774.
48. Gingras, S., E. Parganas, A. de Pauw, J. N. Ihle, and P. J. Murray. 2004. Reexamination of the role of suppressor of cytokine signaling 1 (SOCS1) in the regulation of toll-like receptor signaling. J. Biol. Chem. 279: 54702-54707. (Pubitemid 40053214)
49. Rani, M. R., and R. M. Ransohoff. 2005. Alternative and accessory pathways in the regulation of IFN-beta-mediated gene expression. J. Interferon Cytokine Res. 25: 788-798. (Pubitemid 43068490)
50. Shimoda, K., K. Kato, K. Aoki, T. Matsuda, A. Miyamoto, M. Shibamori, M. Yamashita, A. Numata, K. Takase, S. Kobayashi, et al. 2000. Tyk2 plays a restricted role in IFN alpha signaling, although it is required for IL-12- mediated T cell function. Immunity 13: 561-571.
51. Uddin, S., E. N. Fish, D. A. Sher, C. Gardziola, M. F. White, and L. C. Platanias. 1997. Activation of the phosphatidylinositol 3-kinase serine kinase by IFN-alpha. J. Immunol. 158: 2390-2397. (Pubitemid 127470026)
52. Uddin, S., B. Majchrzak, J. Woodson, P. Arunkumar, Y. Alsayed, R. Pine, P. R. Young, E. N. Fish, and L. C. Platanias. 1999. Activation of the p38 mitogen-activated protein kinase by type I interferons. J. Biol. Chem. 274: 30127-30131.
53. Li, Y., H. Deng, D. Zheng, and H. Li. 2004. Role of p38 mitogen-activated protein kinase in mediating monocyte chemoattractant protein-1 in human umbilical vein endothelial cells. Chin. Med. Sci. J. 19: 71. (Pubitemid 38470347)
54. Mayer, I. A., A. Verma, I. M. Grumbach, S. Uddin, F. Lekmine, F. Ravandi, B. Majchrzak, S. Fujita, E. N. Fish, and L. C. Platanias. 2001. The p38 MAPK pathway mediates the growth inhibitory effects of interferon-alpha in BCRABL- expressing cells. J. Biol. Chem. 276: 28570-28577.
55. Barber, S. A., J. L. Uhrlaub, J. B. DeWitt, P. M. Tarwater, and M. C. Zink. 2004. Dysregulation of mitogen-activated protein kinase signaling pathways in simian immunodeficiency virus encephalitis. Am. J. Pathol. 164: 355-362. (Pubitemid 38364651)
56. Yang, J., and G. R. Stark. 2008. Roles of unphosphorylated STATs in signaling. Cell Res. 18: 443-451. (Pubitemid 351498851)
57. Chatterjee-Kishore, M., R. Kishore, D. J. Hicklin, F. M. Marincola, and S. Ferrone. 1998. Different requirements for signal transducer and activator of transcription 1alpha and interferon regulatory factor 1 in the regulation of low molecular mass polypeptide 2 and transporter associated with antigen processing 1 gene expression. J. Biol. Chem. 273: 16177-16183. (Pubitemid 28311390)
58. Chatterjee-Kishore, M., K. L. Wright, J. P. Ting, and G. R. Stark. 2000. How Stat1 mediates constitutive gene expression: A complex of unphosphorylated Stat1 and IRF1 supports transcription of the LMP2 gene. EMBO J. 19: 4111-4122. (Pubitemid 30608549)
59. Kumar, A., M. Commane, T. W. Flickinger, C. M. Horvath, and G. R. Stark. 1997. Defective TNF-alpha-induced apoptosis in STAT1-null cells due to low constitutive levels of caspases. Science 278: 1630-1632. (Pubitemid 27516283)
60. Stephanou, A., T. M. Scarabelli, B. K. Brar, Y. Nakanishi, M. Matsumura, R. A. Knight, and D. S. Latchman. 2001. Induction of apoptosis and Fas receptor/Fas ligand expression by ischemia/reperfusion in cardiac myocytes requires serine 727 of the STAT-1 transcription factor but not tyrosine 701. J. Biol. Chem. 276: 28340-28347.
61. Nguyen, H., M. Chatterjee-Kishore, Z. Jiang, Y. Qing, C. V. Ramana, J. Bayes, M. Commane, X. Li, and G. R. Stark. 2003. IRAK-dependent phosphorylation of Stat1 on serine 727 in response to interleukin-1 and effects on gene expression. J. Interferon Cytokine Res. 23: 183-192. (Pubitemid 36528981)
62. Brown, G. C., and J. J. Neher. 2010. Inflammatory neurodegeneration and mechanisms of microglial killing of neurons. Mol. Neurobiol. 41: 242-247.
63. Müller, U., U. Steinhoff, L. F. Reis, S. Hemmi, J. Pavlovic, R. M. Zinkernagel, and M. Aguet. 1994. Functional role of type I and type II interferons in antiviral defense. Science 264: 1918-1921. (Pubitemid 24245635)
64. Ryman, K. D., W. B. Klimstra, K. B. Nguyen, C. A. Biron, and R. E. Johnston. 2000. Alpha/beta interferon protects adult mice from fatal Sindbis virus infection and is an important determinant of cell and tissue tropism. J. Virol. 74: 3366-3378. (Pubitemid 30143762)
65. van Heteren, J. T., F. Rozenberg, E. Aronica, D. Troost, P. Lebon, and T. W. Kuijpers. 2008. Astrocytes produce interferon-alpha and CXCL10, but not IL-6 or CXCL8, in Aicardi-Goutiéres syndrome. Glia 56: 568-578.
66. Crow, Y. J., D. N. Black, M. Ali, J. Bond, A. P. Jackson, M. Lefson, J. Michaud, E. Roberts, J. B. Stephenson, C. G. Woods, and P. Lebon. 2003. Cree encephalitis is allelic with Aicardi-Goutiéres syndrome: Implications for the pathogenesis of disorders of interferon alpha metabolism. J. Med. Genet. 40: 183-187. (Pubitemid 36315389)
67. Shakil, A. O., A. M. Di Bisceglie, and J. H. Hoofnagle. 1996. Seizures during alpha interferon therapy. J. Hepatol. 24: 48-51. (Pubitemid 26037205)
68. Schaefer, M., M. A. Engelbrecht, O. Gut, B. L. Fiebich, J. Bauer, F. Schmidt, H. Grunze, and K. Lieb. 2002. Interferon alpha (IFNalpha) and psychiatric syndromes: A review. Prog. Neuropsychopharmacol. Biol. Psychiatry 26: 731-746. (Pubitemid 34615979)
69. Dieperink, E., M. Willenbring, and S. B. Ho. 2000. Neuropsychiatric symptoms associated with hepatitis C and interferon alpha: A review. Am. J. Psychiatry 157: 867-876. (Pubitemid 30412335)
70. Amodio, P., E. N. De Toni, L. Cavalletto, D. Mapelli, E. Bernardinello, F. Del Piccolo, C. Bergamelli, R. Costanzo, F. Bergamaschi, S. Z. Poma, et al. 2005. Mood, cognition and EEG changes during interferon alpha (alpha-IFN) treatment for chronic hepatitis C. J. Affect. Disord. 84: 93-98. (Pubitemid 40037785)
71. Ban, M., A. Goris, A. R. Lorentzen, A. Baker, T. Mihalova, G. Ingram, D. R. Booth, R. N. Heard, G. J. Stewart, E. Bogaert, et al; Wellcome Trust Case- Control Consortium (WTCCC). 2009. Replication analysis identifies TYK2 as a multiple sclerosis susceptibility factor. Eur. J. Hum. Genet. 17: 1309-1313.
72. Mero, I. L., A. R. Lorentzen, M. Ban, C. Smestad, E. G. Celius, J. H. Aarseth, K. M. Myhr, J. Link, J. Hillert, T. Olsson, et al. 2010. A rare variant of the TYK2 gene is confirmed to be associated with multiple sclerosis. Eur. J. Hum. Genet. 18: 502-504.
73. Bieber, A. J., K. Suwansrinon, J. Kerkvliet, W. Zhang, L. R. Pease, and M. Rodriguez. Allelic variation in the Tyk2 and EGF genes as potential genetic determinants of CNS repair. Proc. Natl. Acad. Sci. USA 107: 792-797.
74. Boutros, T., E. Croze, and V. W. Yong. 1997. Interferon-beta is a potent promoter of nerve growth factor production by astrocytes. J. Neurochem. 69: 939-946. (Pubitemid 27364813)
75. Chabot, S., and V. W. Yong. 2000. Interferon beta-1b increases interleukin-10 in a model of T cell-microglia interaction: Relevance to MS. Neurology 55: 1497-1505.
76. Paul, S., C. Ricour, C. Sommereyns, F. Sorgeloos, and T. Michiels. 2007. Type I interferon response in the central nervous system. Biochimie 89: 770-778. (Pubitemid 47008947)